Explore

Trendline Trendline
Circular Genomics Appoints Alzheimer's Biomarker Expert to Advisory Board

Circular Genomics Appoints Alzheimer's Biomarker Expert to Advisory Board

Circular Genomics Appoints Alzheimer's Biomarker Expert to Advisory Board
Rapid Read Rapid Read
Dopamine Dysfunction Identified as Key Factor in Alzheimer's Memory Loss

Dopamine Dysfunction Identified as Key Factor in Alzheimer's Memory Loss

A new study has identified dopamine dysfunction in the entorhinal cortex as a significant factor in Alzheimer's-related memory loss. Researchers found that dopamine levels in this critical brain region drop to less than one-fifth of normal levels in Alzheimer's models, impairing the ability to encode new experiences. The study demonstrated that memory could be restored using Levodopa, a drug already approved for Parkinson's disease. This discovery shifts the focus from toxic proteins like amyloid-beta and tau to neuronal circuits, offering a new therapeutic approach for Alzheimer's treatment.
Rapid Read Rapid Read
Advancements in Astrocyte-Specific Therapies Offer New Hope for Neurological Disorders

Advancements in Astrocyte-Specific Therapies Offer New Hope for Neurological Disorders

Recent research has highlighted the potential of astrocyte-specific therapies in treating neurological disorders. Astrocytes, a type of glial cell in the brain, play a crucial role in supporting neurons and maintaining brain function. The study focuses on targeting molecules and pathways specific to astrocytes, such as GFAP and vimentin, which are involved in reactive astrogliosis—a process linked to neurotrauma and neurodegenerative diseases. By modulating these pathways, researchers aim to develop therapies that can mitigate the effects of conditions like Alzheimer's disease, stroke, and amyotrophic lateral sclerosis (ALS). Current clinical trials are exploring the efficacy of GFAP-targeted antisense nucleotides in treating Alexander disease, a rare neurological disorder.
Rapid Read Rapid Read
UC Irvine Researchers Identify Dopamine Dysfunction as Key Factor in Alzheimer's Memory Loss

UC Irvine Researchers Identify Dopamine Dysfunction as Key Factor in Alzheimer's Memory Loss

Researchers at the University of California, Irvine have discovered that dopamine dysfunction in the entorhinal cortex, a critical brain region for memory, plays a significant role in memory impairment associated with Alzheimer's disease. The study, published in Nature Neuroscience, reveals that dopamine levels in this area are reduced by over 80%, hindering neurons' ability to form associative memories. The research team, led by Kei Igarashi, demonstrated that memory function could be restored in mice using Levodopa, a drug commonly used for Parkinson's disease. This approach contrasts with current treatments that focus on clearing protein plaques, suggesting a new therapeutic strategy that targets neuronal circuits. The findings open the possibility of repurposing Levodopa for clinical trials to address early memory loss in Alzheimer's patients.
Rapid Read Rapid Read
Theradaptive Completes Enrollment in RESTORE Study for Bone Regeneration in Dental Procedures

Theradaptive Completes Enrollment in RESTORE Study for Bone Regeneration in Dental Procedures

Theradaptive, Inc. has announced the completion of patient enrollment in the RESTORE International Phase I/II Feasibility Study, which evaluates the safety and performance of OsteoAdapt® DE, a regenerative product designed to promote bone growth in alveolar ridge augmentation. This study marks a critical milestone in advancing bone regeneration for dental reconstruction using Theradaptive's targeted therapeutic platform. The study is supported by the Armed Forces Institute of Regenerative Medicine and aims to address complex craniomaxillofacial procedures, potentially offering new treatment options for patients with limited choices.
Rapid Read Rapid Read
AI Technology Assesses Breast Cancer Risk Through Cellular Mechanics

AI Technology Assesses Breast Cancer Risk Through Cellular Mechanics

Researchers at City of Hope and the University of California, Berkeley have developed a novel microfluidic platform, known as mechano-node-pore sensing (mechano-NPS), to assess breast cancer risk by analyzing the mechanical properties of human mammary epithelial cells. This platform measures how cells deform and recover when subjected to stress, providing a 'mechanical age' that correlates with breast cancer susceptibility. The study, published in eBioMedicine, highlights that cells from older women are stiffer and take longer to recover, indicating a higher risk of breast cancer. The researchers also developed a machine learning algorithm, MechanoAge, to estimate chronological age and a risk index, Mechano-RISQ, based on these mechanical properties.
Rapid Read Rapid Read
Texas A Researchers Develop Nasal Spray to Combat Brain Aging and Memory Loss

Texas A Researchers Develop Nasal Spray to Combat Brain Aging and Memory Loss

Researchers at Texas A&M University have developed a nasal spray that shows promise in reversing brain inflammation and restoring memory, according to a recent study. The spray, tested on mice, targets 'neuroinflammaging,' a condition linked to brain fog and cognitive decline associated with aging. The study, published in the Journal of Extracellular Vesicles, highlights the spray's potential to replace invasive procedures and long-term medication. The treatment utilizes extracellular vesicles (EVs) to deliver microRNAs directly to the brain, bypassing its protective barriers. These microRNAs suppress protein systems that drive chronic inflammation and recharge mitochondria within neurons, effectively reducing oxidative stress and enhancing brain function.
Rapid Read Rapid Read
UC San Diego Researchers Identify Gene Signal Linked to Alzheimer's Resilience

UC San Diego Researchers Identify Gene Signal Linked to Alzheimer's Resilience

Researchers at the University of California San Diego have identified a gene signal associated with cognitive resilience in Alzheimer's disease. This discovery highlights why some individuals with Alzheimer's brain damage maintain normal cognitive function. The study found a 40-gene pattern that distinguishes between normal aging, symptomatic Alzheimer's, and a resilient state. Chromogranin A (CgA), a stress-related protein, was identified as a key factor in this resilience. Removing CgA in mice showed that brain damage did not necessarily lead to cognitive decline, offering insights into potential protective mechanisms against Alzheimer's.
Trendline Trendline
CareDx Showcases Precision Medicine Advancements at Heart and Lung Transplantation Meeting

CareDx Showcases Precision Medicine Advancements at Heart and Lung Transplantation Meeting

CareDx Showcases Precision Medicine Advancements at Heart and Lung Transplantation Meeting
Rapid Read Rapid Read
CRISPR Base Editing Shows Promise for Cystic Fibrosis Mutation

CRISPR Base Editing Shows Promise for Cystic Fibrosis Mutation

Researchers have developed a CRISPR-based gene therapy to address a challenging mutation in cystic fibrosis (CF) patients. The study, published in Science Translational Medicine, focuses on the 1717-1G>A mutation, which affects a subset of CF patients who do not benefit from existing therapies. The team used an adenine base editing strategy to correct this mutation in cell models, achieving significant editing efficiency with minimal off-target effects. This approach could potentially offer a new treatment avenue for patients with this specific mutation, who currently have limited options.
Trendline Trendline
CareDx Showcases Precision Medicine Advancements at ISHLT Annual Meeting

CareDx Showcases Precision Medicine Advancements at ISHLT Annual Meeting

CareDx Showcases Precision Medicine Advancements at ISHLT Annual Meeting
Trendline Trendline
LiquidCell Dx Appoints Mirna Jarosz as CEO to Advance Tumor Profiling Platform

LiquidCell Dx Appoints Mirna Jarosz as CEO to Advance Tumor Profiling Platform

LiquidCell Dx Appoints Mirna Jarosz as CEO to Advance Tumor Profiling Platform